Classic Cases
Your Location: Home > Classic Cases > Study Cases >
  • ARM China

    Investment quota: >1b RMB

    Fusing Arm’s world-leading industry ecosystem resources and technological excellence with local innovation and growth through Chinese partnerships, Arm China is focused on becoming the leading intellectual property development and service platform for supporting and promoting the rapid development of the electronic industry in china.
    As the headquarter of Arm’s IP business in China, arm china will license arm technology to partners headquarter in China who in turn will continue to supply their products globally. Arm China will also provide independent research and development for Arm-based IP and technology addressing China’s pressing market needs to support local innovation.
  • Tsinghua Bio Technology

    Investment: RMB>100 million

    China's leading bio-pharmaceutical company, including in vitro diagnostic reagents, equipment and third-party testing and a series of products and services. It's a Tsinghua University subsidiary enterprise. The average sales and profit growth rate is more than 30%. Red Horse Investment participated as a strategic investor in its pre-IPO stage.
  • Amlogic

    Investment: US Dollar>10 million

    Crystal Morning Semiconductor(Shanghai)was founded in July 11,2003,the registered capital of US111.9446 million, has 24 patents, the product T866 Amlogic was given the title of the most promising product in the "Tenth China Core Selection". Accounting for more than 50% of market share of the smart set-top boxes chip market, expected to be in the GEM IPO 2015.
  • Quectel Wireless Solutions

    Investment quota: >100m RMB

    Established in 2010, Quectel Wireless Solutions is a leading global supplier of LTE, UMTS/HSPA(+), GSM/GPRS and GNSS modules. Headquartered in Shanghai, China, it boasts of 32 sales technical support offices, 2 R&D centers, 70+ global distributors. It is one of the world’s top five module suppliers. Quectel’s market share is considerably high, and they have formed strong strategic cooperation with their contemporaries, such as Qualcomm and Huawei. 
  • Lizhong Wheel Group

    Investment quota: >10m RMB

    Lizhong Wheel Group is one of China's biggest manufacturers of aluminum alloy wheels. Established in 1995 and listed on the SGX in 2005, it is the first company in its industry to become listed. It now has the annual capacity of 15 million wheels, an annual output/sale putting it in the top-three of its industry and plans to reach 22 million by 2020. Lizhong's clients are comprised of big-name car brands from around the globe: BMW, Volkswagen, Audi, etc.
  • PolyPid

    Investment quota: >1m USD

    Founded in 2008 and located in Israel, PolyPid is a clinical stage,specialty pharmaceutical company that developed a polymer drug delivery platform technology in the field of extend release, local drug delivery for the healthcare industry, enabling a controlled and prolonged release of any active pharmaceutical ingredients (API), including small molecules, peptides,antibodies & other proteins and nucleic acids based drugs, etc.
    IPO is planned for the 1st quarter of 2018 with world leading IB Goldman Sachs as the underwriter at current pre-IPO company value of $165M.
7 total previous 1 2 next